MED’s New Center for Translational Neuroimaging

The School of Medicine’s new Center for Translational Neuroimaging (CTNI), made possible by a $4.9 million grant from the Massachusetts Life Sciences Center, will improve brain imaging techniques and open doors to developing diagnostics and treatments for neurodegenerative diseases. One of the center’s aims is to pioneer biomarkers, diagnostics, and therapeutics for neurodegenerative diseases like Alzheimer’s and chronic traumatic encephalopathy. The CTNI’s advanced 3.5 T Phillips and 9.4T Bruker MRIs and other new equipment will make it possible to track subtle brain changes caused by traumatic head injuries or degenerative neurological disorders. The center will collaborate with clinicians and researchers at Boston Medical Center, BU’s teaching hospital, which has the busiest level 1 trauma and emergency services in the region. Pictured (from left): MRI technician Andy Ellison and CTNI codirectors Stephan Anderson, a MED professor of radiology, and Lee Goldstein, a MED associate professor of neurology. Photo by Cydney Scott